Risk factors contributing to a low darunavir plasma concentration

Darunavir is an efficacious drug; however, pharmacokinetic variability has been reported. The objective of this study was to find predisposing factors for low darunavir plasma concentrations in patients starting the once‐ or twice‐daily dosage. Darunavir plasma concentrations from January 2010 till...

Descripción completa

Detalles Bibliográficos
Autores principales: Daskapan, Alper, Stienstra, Ymkje, Kosterink, Jos G. W., Bierman, Wouter F. W., van der Werf, Tjip S., Touw, Daan J., Alffenaar, Jan‐Willem C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Pharmacokinetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809517/
https://www.ncbi.nlm.nih.gov/pubmed/29077230
http://dx.doi.org/10.1111/bcp.13464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809517/
https://www.ncbi.nlm.nih.gov/pubmed/29077230
http://dx.doi.org/10.1111/bcp.13464

Ejemplares similares